|Articles|February 2, 2005

Pharmaceutical Technology

  • Pharmaceutical Technology-02-02-2005
  • Volume 29
  • Issue 2

Drug Safety Fears May Limit Reimporting and Shape R&D

Author(s)Jill Wechsler

Concerns about risky medicines may reduce pressure to expand drug imports while boosting demand for more comparative analyses of therapies.
External Link - article-146233.pdf

Articles in this issue

almost 21 years ago

Correcting the Course

almost 21 years ago

Using Extrusion-Spheronization to Develop Controlled-Release Formulations of Azithromycin

almost 21 years ago

Toward a Generic Approach for Stress Testing of Drug Substances and Drug Products

almost 21 years ago

February 2005

almost 21 years ago

Good Work and True: USP Prepares for Convention 2005

almost 21 years ago

Contract Manufacturers Getting Squeezed

almost 21 years ago

In the Spotlight-February 2005

almost 21 years ago

Emerging Analytical Technology: Moving from the Lab to the Line

almost 21 years ago

In Defense of USP Singlet Testing

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content